Clear Alpha Technologies LP Cerevel Therapeutics Holdings, Inc. Transaction History
Clear Alpha Technologies LP
- $302 Billion
- Q2 2024
A detailed history of Clear Alpha Technologies LP transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Clear Alpha Technologies LP holds 149,438 shares of CERE stock, worth $0. This represents 2.02% of its overall portfolio holdings.
Number of Shares
149,438
Previous 87,118
71.54%
Holding current value
$0
Previous $3.68 Billion
65.94%
% of portfolio
2.02%
Previous 1.55%
Shares
3 transactions
Others Institutions Holding CERE
# of Institutions
270Shares Held
155MCall Options Held
2.19MPut Options Held
3.92M-
Bain Capital Investors LLC Boston, MA65.7MShares$065.37% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$012.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.54MShares$04.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.15MShares$00.01% of portfolio
-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...